Maite, Edvin, Fredrik and I am now at a the European Nanomedicine meeting in Grenoble. Maite and Fredrik presented two posters on encapsulation of tyrosine hydroxylase in maltodextrine nanoparticles, and the results on brain delivery of these. Edvin presented one poster with our latest results on nanoencapsulation of chlorpromazine in liposomes and PLGA nanospheres. Today is the last day, and there has been several interesting talks, given the perspective on the whole process from development of novel nanoparticles to clinical trials. It has been long days, and little time to see the city, but here are some impressions from our way between the hotel and the conference venue. Continue reading Nanomeeting in Grenoble
The first 2016-issue of Current Pharmaceutical Biotechnology will be a review issue dedicated to latest research on acute myeloid leukaemia (AML). Prof. Frode Selheim at Department of Biomedicine and myself were guest editors, and we managed to get contributions from several outstanding researchers ranging from clinicians to natural compound chemists and microbiologists. I grouped with Dr. Gillian Barratt and Juliette Vergnaud, and PhD candidate Félix Sauvage, to write a review on the potential of using nanocarriers in AML therapy. You can find the whole list of papers here.